Sitagliptin Phosphate

Preferred Label : Sitagliptin Phosphate;

NCIt definition : The phosphate salt form of sitagliptin, an orally available, competitive, beta-amino acid-derived inhibitor of dipeptidyl peptidase 4 (DDP-4) with hypoglycemic activity. Sitagliptin may cause an increased risk in the development of pancreatitis.;

UNII : TS63EW8X6F;

InChIKey : GQPYTJVDPQTBQC-KLQYNRQASA-N;

CAS number : 654671-77-9;

Drug name : Januvia;

Chemical formula : C16H15F6N5O.H2O.H3O4P;

Details

Origin ID

C73811;

UMLS CUI

C1667080;

CISMeF manual mappings
- Sitagliptin Phosphate [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Sitagliptin Phosphate [MeSH Descriptor]
- Sitagliptin phosphate (substance) [SNOMED CT concept]
- sitagliptin phosphate [MeSH concept]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
has_free_acid_or_base_form
- Sitagliptin [NCIt concept]
has_target
- Dipeptidyl Peptidase 4 [NCIt concept]
is_salt_form_of
- Sitagliptin [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients